A Red-Dot and A’Prime Design award-winner and the first Industrial Designer in Singapore to be awarded the Doctoral of Philosophy (PhD) qualification from the National University of Singapore (NUS), Associate Professor Agnes Xue received the NUS President’s Graduate Fellowship and was a NUS Research Scholar, investigating on better approaches in the design of self-care devices and applications for women’s health.

Her research interest has always been exploring better designs for healthcare that will have user-centric impact in this digital age. She is a regular panellist and peer reviewer in the areas of healthcare design and innovation. Prior to her role as Head of Design Factory@SIT, she was the Co-Chair of Business, Communication and Design Cluster Applied Research Committee, and Programme Director of design programmes at the Singapore Institute of Technology (SIT). Her professional and teaching experience includes work at Siemens Medical Instruments, the Design Singapore Council, NUS and the Singapore Stanford Biodesign office of A*STAR-EDB. Her career experience includes direct responsibility in grant management, principal investigatorships, and various cross-functional change teams.

During her time outside of the university, she has invested and started two design consultancies. In her personal capacity, she volunteered in the Lupus Association Singapore EXCO for the past decade.

As the Chief Marketing Officer and Chief Business Officer at AWAK Technologies Pte Ltd, Mandar Gori leads Marketing, Clinical and Business Development departments. He was instrumental in successfully closing the largest MedTech Series A funding round in Singapore of US$ 40 million. Under his leadership, US FDA granted Breakthrough Device Designation to AWAK’s wearable dialysis product in 2019, a major milestone for AWAK as it became first in the region to achieve this designation and the first globally in the kidney care industry. In 2018 AWAK completed its First-In-Human clinical trial in Singapore General Hospital proving for the first time safety of a wearable artificial kidney.

Prior to AWAK, Mandar was Deputy Director at Agency for Science, Technology and Research (A*STAR), Singapore's premier R&D and commercialisation agency, where he successfully established programs to train and develop local MedTech talent and give them an in-depth understanding of other regional healthcare markets. As a Commercial Manager at Hill-Rom (acquired by Baxter in 2021), a global $12 Billion medical device manufacturer, Mandar successfully launched several products in the Asian markets. In his role at Hill-Rom he managed sales channels across ASEAN, S.Korea, Hong Kong, Taiwan and Indian sub-continent for the entire product portfolio of the company. In his early career, Mandar was a Project Manager for a US-based digital health start-up MedMined Inc where he launched several one-of-a-kind products which gave unmatched clinical intelligence at point-of-care. These solutions based on data mining and artificial intelligence were first in their categories to show better clinical outcomes and cost savings in the areas of hospital-acquired infections and medication errors. MedMined was later acquired by Cardinal Health, spun-off into CareFusion and then acquired by Becton Dickinson (BD).

Mandar has a keen interest in talent development. He was a mentor at Junior Achievement in Singapore, one of the world’s largest non-profit organisation dedicated to inspire and prepare younger generation to succeed in a global economy. As a teaching volunteer at Akanksha Foundation he mentored underprivileged kids from urban areas in India.

Mandar has a MBA from Nanyang Business School (Singapore), MS in Healthcare Informatics from University of Alabama at Birmingham (USA) and BE in Information Technology from Mumbai University (India). He also has several patents related to technologies in kidney care under his name.

Pru specialises in healthcare innovation and commercialisation. As a serial medtech entrepreneur, he has deep hands-on knowledge of many critical aspects of medtech product development/commercialisation including product conceptualisation, regulatory strategy, product-market fit, clinical trials, and regulatory clearance. As a former Fellow in the highly-competitive Stanford Biodesign Fellowship program, Pru utilises the Biodesign process as a key tool for innovation strategy. Apart from his entrepreneurship work, he has mentored numerous startups, industry teams and students in official and unofficial capacities. Pru served as a Fellowship Consultant for the Singapore-Stanford Biodesign program, where he worked closely with the Fellowship Head to train Singapore-Stanford Biodesign Fellows and to develop new training programs. He has also served in mentorship roles at National University of Singapore, such as the Lean Launchpad and the Graduate Research Innovation Program (GRIP). Many of the teams he mentored have gone on to raise further funding.

Ms. Tan Hwee Ee is the Founder of DH RegSys in Singapore and Co‐Founder of MD‐CLINICALS Malaysia, a clinical research organization which manages 100% medical devices.

She has more than 20 years of experience in the medical industry principally in medical device organisations as a consultant, engineer, and senior manager.

She is a Subject Matter Expect (SME) for WMDO (World Medical Device Organisation), and provides consulting and training services and product solutions to the medical device and related industries for regulatory bodies such as Singapore HSA, Malaysia MDA, Australia TGA, US FDA, EU and more.